Leap Therapeutics (LPTX) Earnings Date & Reports

Leap Therapeutics Inc is a biopharmaceutical company developing novel biomarker-targeted antibody therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways, targeting cancer-specific cell surface molecules, and harnessing the immune system to attack cancer cells... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

LPTX is expected to report earnings to fall 76.84% to -8 cents per share on August 11

Leap Therapeutics LPTX Stock Earnings Reports

Q2'23

Est.

$-0.09

Q4'24

Beat

by $0.33

Q1'23

Missed

by $0.23

Q4'22

Est.

$-0.11

Q3'22

Missed

by $0.01

The last earnings report on March 26 showed earnings per share of -37 cents, beating the estimate of -70 cents. With 321.75K shares outstanding, the current market capitalization sits at 15.93M.

View a ticker or compare two or three

Compare

LPTX